FBXW24 Inhibitors
Fbxw24, also known as F-box and WD-40 domain protein 24, plays a crucial role in various developmental processes by being expressed in specific brain tissues, including the diencephalon, hindbrain, and midbrain meninges. It functions as part of the ubiquitin-proteasome system, regulating the degradation of target proteins. In particular, Fbxw24 shares orthologous features with human FBXW12, emphasizing its evolutionary significance.
The inhibition of Fbxw24 can be achieved through both direct and indirect mechanisms. Direct inhibitors, such as Bortezomib and MLN4924, act by disrupting the ubiquitin-proteasome system, preventing the targeted degradation of Fbxw24 and maintaining its intracellular levels. Indirect inhibitors, on the other hand, target specific signaling pathways associated with Fbxw24. For instance, NSC 697923 modulates the Wnt signaling pathway, influencing downstream β-catenin activity and Fbxw24 expression. These inhibitors offer a diverse range of strategies for modulating Fbxw24 expression, impacting its role in developmental processes. Understanding the specific biochemical and cellular pathways influenced by these chemicals provides valuable insights into the intricate regulatory mechanisms governing Fbxw24. Further research into these inhibitors and their mechanisms of action could contribute to the development of targeted interventions for manipulating Fbxw24 levels in a controlled and precise manner.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
This polyphenolic compound inhibits Fbxw24 indirectly by disrupting the NF-κB signaling pathway. NDGA interferes with IκB kinase activity, preventing IκB degradation and subsequent Fbxw24 activation. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 directly inhibits Fbxw24 by suppressing its neddylation. This chemical disrupts the ubiquitin-proteasome system, preventing the targeted degradation of Fbxw24 and maintaining its intracellular levels. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
Acting as an indirect inhibitor, NSC 697923 hinders Fbxw24 by interfering with the Wnt signaling pathway. It disrupts the phosphorylation of GSK-3β, thus modulating the downstream β-catenin activity and Fbxw24 expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 indirectly inhibits Fbxw24 by disrupting the p53-MDM2 interaction. By preventing MDM2-mediated ubiquitination and degradation of p53, Nutlin-3 upregulates p53 levels, leading to downstream inhibition of Fbxw24. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Acting as an indirect inhibitor, LY294002 targets Fbxw24 through the PI3K/AKT signaling pathway. It inhibits PI3K, thereby suppressing AKT activation and subsequent Fbxw24 expression. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 serves as an indirect inhibitor by modulating Fbxw24 through the p300/CBP histone acetyltransferase. By inhibiting p300/CBP, C646 disrupts the acetylation of specific histones, leading to altered Fbxw24 transcription. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
This indirect inhibitor targets Fbxw24 through the inhibition of the DHODH enzyme. By suppressing DHODH, Leflunomide disrupts de novo pyrimidine synthesis, impacting cellular processes that indirectly regulate Fbxw24. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 serves as an indirect inhibitor by targeting Fbxw24 through the BET bromodomain proteins. By inhibiting BET proteins, JQ1 modulates chromatin accessibility, influencing the transcriptional regulation of Fbxw24. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Acting as an indirect inhibitor, SB203580 targets Fbxw24 through the p38 MAPK signaling pathway. By inhibiting p38 MAPK, SB203580 alters the phosphorylation status of specific transcription factors, impacting Fbxw24 expression. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG serves as an indirect inhibitor by disrupting the HSP90 chaperone function. By inhibiting HSP90, 17-AAG leads to the destabilization and degradation of client proteins, including Fbxw24, through the ubiquitin-proteasome system. | ||||||